Zoetis Inc - Class A
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock producers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees.
Did you know?
Trading 82% below its estimated fair value of $207.59.
Current Price
$114.16
-0.70%GoodMoat Value
$207.59
81.8% undervaluedProfile
Valuation (TTM)
Market Cap$50.31B
P/E18.82
EV$57.71B
P/B15.10
Shares Out440.69M
P/Sales5.31
Revenue$9.47B
EV/EBITDA14.07
Zoetis Inc - Class A (ZTS) Stock News
ZTS Stock News & Headlines
Latest stock news and headlines for Zoetis Inc - Class A (ZTS). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $114.16. Market cap: $50.31B. Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. This page aggregates the latest news articles relevant to ZTS from financial news sources, helping investors stay current on events that may impact Zoetis Inc - Class A's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Zoetis Inc - Class A (ZTS).